At the 2014 annual conference of the Academic Centres of Excellence in Cyber-Security Research I was invited to give a talk on commercialising research from the viewpoint of an academic. I did that by distilling the widsom and experience of five of my Cambridge colleagues who had started a company (or several). The talk was well received at the conference and may be instructive both for academics with entrepreneurial ambitions and for other universities that aspire to replicate the “Cambridge phenomenon” elsewhere.
A recording of the presentation, Commercialising research: the academic’s perspective from Frank Stajano Explains, is available on Vimeo.
Security economics is a thriving research discipline, kicked off in 2001 with Ross Anderson’s seminal paper. There has been an annual workshop since 2002. In recent years there has also been an effort to integrate some of the key concepts and findings into course curricula, including in the Part II Security course at Cambridge and my own course at SMU.
We are pleased to announce that on 20 January 2015, we will launch an online course on the Economics of Cybersecurity, as part of edX Professional Education. The course provides a thorough introduction to the field, delivered by leading researchers from Delft University of Technology, University of Cambridge, University of Münster and Southern Methodist University. Continue reading Economics of Cybersecurity MOOC
I have written a letter to Stephen Dorrell, the chair of the Health Committee, to point out how officials appear to have misled his committee when they gave evidence there on Tuesday.
It is very welcome that the Health Secretary, Jeremy Hunt, announced he will change the law to ban the sale of our medical records collected via HES and care.data. He acted after it became clear that although officials told the Health Committee that our records collected via care.data could not legally be sold, records collected via a different system (HES) already had been. But that is not all.
Officials also said our records would not be sold abroad, and that only coded data would be extracted rather than free text entered by GPs during consultations. Yet our records were offered for sale in the USA; the Department signed a memorandum of understanding with the USA on data sharing; and CPRD (a system operated by MHRA, the regulator) has been supplying free text for mining.
I also sent Mr Dorrell a previously unpublished briefing I wrote for the European Commission last year on the potential harm that can follow if patients lose confidence in confidentiality. Evidence from the USA and elsewhere suggests strongly that tens of thousands of people would seek treatment late, or not at all.